
Ardent Health, Inc.: updates and filings
Price
$14.98
November 20, 2026Market cap $2.1B
What Ploutos Investor adds for Ardent Health
Part of Ploutos Investor, €9.99 a month
- The full history: 4 fiscal years, from 2022
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Feb 4, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
October 2026
September 2026
August 2026
June 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 19, 2026Other material eventsForm8-K
- Nov 12, 2026Regulation FD disclosureForm8-K
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 4, 2026Results of operationsForm8-K
- Oct 23, 2026Officer or director changeForm8-K
- Sep 4, 2026Other material eventsForm8-K
- Aug 10, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 4, 2026Results of operationsForm8-K
- Jun 30, 2026Officer or director changeForm8-K
- Jun 2, 2026Officer or director change, Regulation FD disclosureForm8-K
- May 26, 2026Shareholder voteForm8-K
- May 6, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 5, 2026Results of operationsForm8-K
- Apr 8, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 8, 2026Additional annual meeting materialFormDEFA14A
- Apr 8, 2026Annual meeting proxy statementFormDEF 14A
- Mar 27, 2026Officer or director changeForm8-K
- Mar 16, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 4, 2026Results of operationsForm8-K
- Nov 18, 2025Regulation FD disclosure, other material eventsForm8-K
- Nov 14, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
- Nov 12, 2025Results of operationsForm8-K
- Sep 23, 2025Material agreement entered, new material financial obligationForm8-K
- Aug 25, 2025FilingFormEFFECT
- Aug 21, 2025Correspondence with the SECFormCORRESP
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 19, 2026 | 8-K | Other material events | Document |
| Nov 12, 2026 | 8-K | Regulation FD disclosure | Document |
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 4, 2026 | 8-K | Results of operations | Document |
| Oct 23, 2026 | 8-K | Officer or director change | Document |
| Sep 4, 2026 | 8-K | Other material events | Document |
| Aug 10, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 4, 2026 | 8-K | Results of operations | Document |
| Jun 30, 2026 | 8-K | Officer or director change | Document |
| Jun 2, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| May 26, 2026 | 8-K | Shareholder vote | Document |
| May 6, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 5, 2026 | 8-K | Results of operations | Document |
| Apr 8, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 8, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 8, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 27, 2026 | 8-K | Officer or director change | Document |
| Mar 16, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 4, 2026 | 8-K | Results of operations | Document |
| Nov 18, 2025 | 8-K | Regulation FD disclosure, other material events | Document |
| Nov 14, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
| Nov 12, 2025 | 8-K | Results of operations | Document |
| Sep 23, 2025 | 8-K | Material agreement entered, new material financial obligation | Document |
| Aug 25, 2025 | EFFECT | Filing | Document |
| Aug 21, 2025 | CORRESP | Correspondence with the SEC | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Oct 26, 2018.
The full analysis
What do Ardent Health's filings show?
The filings are where every one of Ardent Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.